Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of M5161 for pruritus in atopic dermatitis
2006-001564-22Phase 2Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of M5161 in atopic dermatitis (AD) (3 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Mean change in pruritus score from baseline. Started Aug 2006; status: completed.
02
Drugs
M5161
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-001564-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001564-22.